Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy.
Katopodi T, Petanidis S, Grigoriadou E, Anestakis D, Charalampidis C, Chatziprodromidou I, Floros G, Eskitzis P, Zarogoulidis P, Koulouris C, Sevva C, Papadopoulos K, Roulia P, Mantalovas S, Dagher M, Karakousis AV, Varsamis N, Vlassopoulos K, Theodorou V, Mystakidou CM, Katsios NI, Farmakis K, Kosmidis C. Katopodi T, et al. Among authors: petanidis s. Pharmaceutics. 2024 Mar 25;16(4):455. doi: 10.3390/pharmaceutics16040455. Pharmaceutics. 2024. PMID: 38675116 Free PMC article. Review.
Expression patterns and clinical implications of PDL1 and DLL3 biomarkers in small cell lung cancer retrospectively studied: Insights for therapeutic strategies and survival prediction.
Domvri K, Yaremenko AV, Apostolopoulos A, Petanidis S, Karachrysafi S, Pastelli N, Papamitsou T, Papaemmanouil S, Lampaki S, Porpodis K. Domvri K, et al. Among authors: petanidis s. Heliyon. 2024 Feb 29;10(5):e27208. doi: 10.1016/j.heliyon.2024.e27208. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38468968 Free PMC article.
Tumor cell metabolic reprogramming and hypoxic immunosuppression: driving carcinogenesis to metastatic colonization.
Katopodi T, Petanidis S, Anestakis D, Charalampidis C, Chatziprodromidou I, Floros G, Eskitzis P, Zarogoulidis P, Koulouris C, Sevva C, Papadopoulos K, Dagher M, Karakousis VA, Varsamis N, Theodorou V, Mystakidou CM, Vlassopoulos K, Kosmidis S, Katsios NI, Farmakis K, Kosmidis C. Katopodi T, et al. Among authors: petanidis s. Front Immunol. 2024 Jan 16;14:1325360. doi: 10.3389/fimmu.2023.1325360. eCollection 2023. Front Immunol. 2024. PMID: 38292487 Free PMC article. Review.
Nebulisation of Paclitaxel, Sotatercept and Iloprost for pulmonary hypertension for lung cancer. From In vitro to In vivo.
Zarogoulidis P, Petridis D, Huang H, Bai C, Pitsiou G, Matthaios D, Perdikouri EI, Papadopoulos V, Petanidis S, Kosmidis C, Hohenforst-Schmidt W, Porpodis K, Kougas N, Oikonomou P, Nikolaou C, Charalampidis C, Sardeli C. Zarogoulidis P, et al. Among authors: petanidis s. J Cancer. 2024 Jan 1;15(4):871-879. doi: 10.7150/jca.90732. eCollection 2024. J Cancer. 2024. PMID: 38230210 Free PMC article.
Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery.
Katopodi T, Petanidis S, Anestakis D, Charalampidis C, Chatziprodromidou I, Floros G, Eskitzis P, Zarogoulidis P, Koulouris C, Sevva C, Papadopoulos K, Dagher M, Varsamis N, Theodorou V, Mystakidou CM, Katsios NI, Farmakis K, Kosmidis C. Katopodi T, et al. Among authors: petanidis s. Pharmaceutics. 2023 Oct 13;15(10):2458. doi: 10.3390/pharmaceutics15102458. Pharmaceutics. 2023. PMID: 37896218 Free PMC article. Review.
Inhaled nintentanib, pirfenidone and macitentan for pulmonary fibrosis: a laboratory experiment.
Zarogoulidis P, Petridis D, Huang H, Bai C, Oikonomou P, Nikolaou C, Matthaios D, Perdikouri EI, Papadopoulos V, Petanidis S, Kosmidis C, Charalampidis C, Hohenforst-Schmidt W, Kougkas N, Sardeli C. Zarogoulidis P, et al. Among authors: petanidis s. Ther Deliv. 2023 Aug;14(8):491-498. doi: 10.4155/tde-2023-0045. Epub 2023 Aug 16. Ther Deliv. 2023. PMID: 37584210
Endobronchial Radiofrequency Ablation for pulmonary nodules with Radial-Ebus and Navigation: Pros and Cons.
Zarogoulidis P, Hohenforst-Schmidt W, Chen W, Porpodis K, Kosmidis C, Kotsakis A, Perdikouri EI, Tolis C, Ioannidis A, Sapalidis K, Matthaios D, Giannakidis D, Oikonomou P, Nikolaou C, Papadopoulos V, Sardeli C, Charalampidis C, Petanidis S, Bai C, Huang H. Zarogoulidis P, et al. Among authors: petanidis s. J Cancer. 2023 May 21;14(9):1562-1570. doi: 10.7150/jca.84894. eCollection 2023. J Cancer. 2023. PMID: 37325061 Free PMC article.
Melanoma: BRAFi Rechallenge.
Kosmidis CS, Papadopoulou K, Mystakidou CM, Papadopoulou E, Mantalovas S, Varsamis N, Koulouris C, Theodorou V, Papadopoulos K, Sevva C, Miltiadous P, Petanidis S, Georgakoudi E, Papadopoulou E, Baka S. Kosmidis CS, et al. Among authors: petanidis s. Medicina (Kaunas). 2023 May 18;59(5):975. doi: 10.3390/medicina59050975. Medicina (Kaunas). 2023. PMID: 37241207 Free PMC article.
Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy.
Katopodi T, Petanidis S, Tsavlis D, Anestakis D, Charalampidis C, Chatziprodromidou I, Eskitzis P, Zarogoulidis P, Kosmidis C, Matthaios D, Porpodis K. Katopodi T, et al. Among authors: petanidis s. Front Oncol. 2022 Oct 21;12:1042125. doi: 10.3389/fonc.2022.1042125. eCollection 2022. Front Oncol. 2022. PMID: 36338748 Free PMC article. Review.
43 results